9R7-20050-92276
2 vaccinations
3 coded responses
28 check-ins
3 free-text entries
1 call case
- Sex
- Female
- Age at first dose
- 31-35
- ZIP prefix
- 930 / CA
- Registered
- 2021-04-06
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-06
Registered in v-safe
-
2021-04-06
Dose 1 — Janssen/Johnson & Johnson
-
2021-04-06
Survey response — day 0, dose 1MedDRA: Hypoaesthesia, Paraesthesia — Feeling: Fair · Site: Pain · Muscle or body achesFree text: Tingling and numbnessMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-07
Survey response — days 1–6 daily, dose 1MedDRA: Blood glucose increased — Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessFree text: Elevated blood glucose levelsMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-09
- 2021-04-10
- 2021-04-11
- 2021-04-12
- 2021-04-13
- 2021-04-20
- 2021-04-27
- 2021-05-04
- 2021-05-11
- 2021-05-18
- 2021-07-06
- 2021-10-05
-
2021-12-29
Dose 2 — Pfizer-BioNTech
- 2021-12-29
- 2021-12-30
- 2021-12-31
- 2022-01-01
- 2022-01-02
- 2022-01-03
- 2022-01-04
- 2022-01-05
- 2022-01-12
- 2022-01-19
- 2022-01-26
- 2022-02-02
- 2022-02-09
-
2022-04-01
Survey response — 3 months, dose 2MedDRA: Pregnancy — Feeling: Good · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultationFree text: I am pregnantMedDRA releases: 2024-11 · check-in free text available
-
2022-04-01
Report sent to call center — 3 months, dose 2Be unable to do your normal daily activities · Get care from a doctor or other healthcare professionalTelehealth, virtual health, or email health consultation · 1 call case(s)
-
2022-04-05
Call successfulNot applicable (accidental reporting or does not believe symptoms are related to vaccine)
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-06 | Janssen/Johnson & Johnson | |
| 2 | 2021-12-29 | Pfizer-BioNTech | No |
Call center
1 call center case
1 successful
Free text
Release 7 — day 0, dose 1
Systemic reaction (other): Tingling and numbness
Release 7 — days 1–6 daily, dose 1
Systemic reaction (other): Elevated blood glucose levels
Release 11 — 3 months, dose 2
Symptoms: I am pregnant
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pregnancy | · | · | ✓ |
| SRO | Blood glucose increased | ✓ | ✓ | ✓ |
| SRO | Hypoaesthesia | ✓ | ✓ | ✓ |
| SRO | Paraesthesia | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release